首页 | 本学科首页   官方微博 | 高级检索  
     

非体外循环下冠状动脉旁路移植术患者不同抗血小板方案对乳内动脉桥血管通畅率影响的临床研究
引用本文:杨昭,李温斌,白瑞凯,宋士秋,周子凡,顾成雄,黄方炯,张健群,伯平. 非体外循环下冠状动脉旁路移植术患者不同抗血小板方案对乳内动脉桥血管通畅率影响的临床研究[J]. 心肺血管病杂志, 2020, 0(3): 276-279
作者姓名:杨昭  李温斌  白瑞凯  宋士秋  周子凡  顾成雄  黄方炯  张健群  伯平
作者单位:首都医科大学附属北京安贞医院-北京市心肺血管病研究所心脏外科中心;河南省人民医院心外科
摘    要:目的:对比研究非体外循环下冠状动脉旁路移植术(OPCABG)后,分别运用单抗(阿司匹林)与双抗(阿司匹林+氯吡格雷)抗血小板治疗后,对远期乳内动脉桥血管通畅率的影响。方法:回顾性分析2005年01月至2005年12月,在安贞医院心脏外科固定手术组行OPCABG并顺利出院的230例患者的临床资料,并对其进行随访。结果:随访时间为150个月,随访期内心脏相关死亡54例(16.4%)。两组前降支通畅率分别为65.8%、66.4%(P>0.05)。结论:对于OPCABG的患者,无论给与双抗或单抗,其远期效果并无明显差异,但短期内前降支通畅率变化趋势,双抗组优于单抗组。

关 键 词:冠心病  冠状动脉旁路移植术  抗凝治疗  桥血管通畅率

Clinical study on the effect of different antiplatelet regimens on patency rate of internal mammary artery bridge after off-pump coronary artery bypass grafting
YANG Zhao,LI Wenbin,BAI Ruikai,SONG Shiqiu,ZHOU Zifan,GU Chengxiong,HUANG Fangjiong,ZHANG Jianqun,BO Ping. Clinical study on the effect of different antiplatelet regimens on patency rate of internal mammary artery bridge after off-pump coronary artery bypass grafting[J]. Journal of Cardiovascular and Pulmonary Diseases, 2020, 0(3): 276-279
Authors:YANG Zhao  LI Wenbin  BAI Ruikai  SONG Shiqiu  ZHOU Zifan  GU Chengxiong  HUANG Fangjiong  ZHANG Jianqun  BO Ping
Affiliation:(Department of Cardiac Surgery,Beijing Anzhen Hospital,Capital Medical University,Beijing Institute of Heart,Lung and Blood Vessel Diseases,Beijing 100029,China)
Abstract:Objective: To compare the effects of antiplatelet therapy with monoclonal antibody(aspirin) and double antibody(aspirin + clopidogrel) on long-term patency of intramammary artery bridge after off-pump coronary artery bypass grafting(OPCABG). Methods: From January 2005 to December 2005, the clinical data of 230 patients who underwent OPCABG and successfully discharged from the same operation group in Anzhen Hospital were analyzed and followed up. Results: The follow-up period was 150 months. 54 cases(16.4%) died of heart-related diseases during the follow-up period. The patency rate of anterior descending branch in the two groups was 65.8% and 66.4%(P>0.05). Conclusions:For patients with OPCABG, there was no significant difference in the long-term effect between the two groups, but in the short term, the patency rate of anterior descending artery in the two groups was better than that in the monoclonal antibody group.
Keywords:Coronary heart disease  Coronary artery bypass grafting  Anticoagulant therapy  Bridging vessel patency rate
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号